Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Bristol-Myers Squibb

Bristol-Myers Squibb reported $19.08B in Current Liabilities for its fiscal quarter ending in March of 2023.

Current Liabilities Change
Abbott ABT:US USD 14.53B 959M
Amgen AMGN:US USD 14.22B 1.47B
AstraZeneca AZN:LN USD 24.86B 1.43B
Biogen BIIB:US USD 3.01B 257.9M
Catalent CTLT:US USD 1.53B 583M
Coherus Biosciences CHRS:US USD 123.41M 15.29M
Drreddys Laboratories RDY:US INR 85.84B 1.46B
Eli Lilly LLY:US USD 16.01B 1.13B
Endo International ENDP:US USD 606.64M 82.98M
Gilead Sciences GILD:US USD 10.53B 709M
GlaxoSmithKline GSK:LN GBP 20.7B 2.11B
Horizon Pharma HZNP:US USD 884.89M 64.25M
Intercept Pharmaceuticals ICPT:US USD 207.12M 22.96M
J&J JNJ:US USD 60.37B 4.57B
Novartis NOVN:VX USD 30.55B 1.89B
Perrigo PRGO:US USD 1.09B 26.8M
Phibro Animal Health PAHC:US USD 165.31M 2.26M
Prestige Brands PBH:US USD 160.72M 539K
Regeneron Pharmaceuticals REGN:US USD 3.1B 41.2M
Revance Therapeutics RVNC:US USD 77.98M 2.3M
Roche Holding ROG:VX CHF 27.24B 170M
United Therapeutics UTHR:US USD 324.6M 18.6M
Zoetis ZTS:US USD 1.92B 1.25B